Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Duijvesz, Diederick ^a   Burnum Johnson, Kristin E ^b   Gritsenko, Marina A ^b   Hoogland, A Marije ^a   Vredenbregt van Den Berg, Mirella S ^a   Willemsen, Rob ^a   Luider, Theo ^a   Paša Tolić, Ljiljana ^c   Jenster, Guido ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXOSOMES; FATTY ACID SYNTHASE, TYPE I; HUMANS; KARYOPHERINS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM PROTEINS; PHOSPHOPYRUVATE HYDRATASE; PROSTATIC NEOPLASMS; PROTEOMICS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84894235330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082589     Document Type: Article

References (44)

1. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, et al. (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916. (Pubitemid 17147932)
2. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360: 1320-1328.
3. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
4. Duijvesz D, Luider T, Bangma CH, Jenster G (2010) Exosomes as Biomarker Treasure Chests for Prostate Cancer. Eur Urol.
5. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21. (Pubitemid 351853251)
6. Di Vizio D, Kim J, Hager MH, Morello M, Yang W, et al. (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69: 5601-5609.
7. Berthon P, Cussenot O, Hopwood L, Leduc A, Maitland N (1995) Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. Int J Oncol 6: 333-343.
8. van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, et al. (1996) Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149: 1055-1062. (Pubitemid 26334187)
9. Korenchuk S, Lehr JE, L MC, Lee YG, Whitney S, et al. (2001) VCaP, a cell-based model system of human prostate cancer. In Vivo 15: 163-168.
10. Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, et al. (2006) The human PC346 xenograft and cell line panel: a model system for prostate cancer progression. Eur Urol 49: 245-257. (Pubitemid 43197860)
11. Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, et al. (2004) Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 164: 1807-1815. (Pubitemid 38529783)
12. Livesay EA, Tang K, Taylor BK, Buschbach MA, Hopkins DF, et al. (2008) Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem 80: 294-302. (Pubitemid 351448434)
13. Zimmer JS, Monroe ME, Qian WJ, Smith RD (2006) Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev 25: 450-482.
14. Yates 3rd JR, Eng JK, McCormack AL, Schieltz D (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67: 1426-1436.
15. Monroe ME, Tolic N, Jaitly N, Shaw JL, Adkins JN, et al. (2007) VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics 23: 2021-2023. (Pubitemid 47299846)
16. Prasad TS, Kandasamy K, Pandey A (2009) Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol 577: 67-79.
17. Polpitiya AD, Qian WJ, Jaitly N, Petyuk VA, Adkins JN, et al. (2008) DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics 24: 1556-1558. (Pubitemid 351911716)
18. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868. (Pubitemid 29003722)
19. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067. (Pubitemid 38520528)
20. Jongeneel CV, Delorenzi M, Iseli C, Zhou D, Haudenschild CD, et al. (2005) An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res 15: 1007-1014. (Pubitemid 40994221)
21. Ge X, Yamamoto S, Tsutsumi S, Midorikawa Y, Ihara S, et al. (2005) Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 86: 127-141. (Pubitemid 40917220)
22. Son CG, Bilke S, Davis S, Greer BT, Wei JS, et al. (2005) Database of mRNA gene expression profiles of multiple human organs. Genome Res 15: 443-450. (Pubitemid 40467786)
23. Shyamsundar R, Kim YH, Higgins JP, Montgomery K, Jorden M, et al. (2005) A DNA microarray survey of gene expression in normal human tissues. Genome Biol 6: R22.
24. Veldhoven A, de Lange D, Smid M, de Jager V, Kors JA, et al. (2005) Storing, linking, and mining microarray databases using SRS. BMC Bioinformatics 6: 192.
25. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11-22.
26. Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, et al. (2010) Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 9: 197-208.
27. Raj DA, Fiume I, Capasso G, Pocsfalvi G (2012) A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. Kidney Int.
28. Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, et al. (2010) Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 9: 1324-1338.
29. Jimenez CR, Knol JC, Meijer GA, Fijneman RJ (2010) Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics 73: 1873-1895.
30. Hosseini-Beheshti E, Pham S, Adomat H, Li N, Tomlinson Guns ES (2012) Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 11: 863-885.
31. Sandvig K, Llorente A (2012) Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3. Mol Cell Proteomics 11: M111 012914.
32. Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, et al. (2013) In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics 13: 1667-1671.
33. Odorizzi G (2006) The multiple personalities of Alix. J Cell Sci 119: 3025-3032.
34. Guescini M, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, et al. (2010) C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res 316: 1977-1984.
35. Hemming FJ, Fraboulet S, Blot B, Sadoul R (2004) Early increase of apoptosis-linked gene-2 interacting protein X in areas of kainate-induced neurodegeneration. Neuroscience 123: 887-895. (Pubitemid 38130099)
36. Liu H, Liu JY, Wu X, Zhang JT (2010) Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol 1: 69-89.
37. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, et al. (2009) Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101: 519-532.
38. Shah US, Dhir R, Gollin SM, Chandran UR, Lewis D, et al. (2006) Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol 37: 401-409.
39. Noske A, Weichert W, Niesporek S, Roske A, Buckendahl AC, et al. (2008) Expression of the nuclear export protein chromosomal region maintenance/ exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer 112: 1733-1743. (Pubitemid 351536833)
40. Stade K, Ford CS, Guthrie C, Weis K (1997) Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90: 1041-1050. (Pubitemid 27408518)
41. Gallouzi IE, Steitz JA (2001) Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294: 1895-1901.
42. Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, et al. (2003) Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem 278: 41998-42005. (Pubitemid 37310463)
43. Jansen FH, Krijgsveld J, van Rijswijk A, van den Bemd GJ, van den Berg MS, et al. (2009) Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins. Mol Cell Proteomics 8: 1192-1205.
44. Subramanian A, Miller DM (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275: 5958-5965. (Pubitemid 30115245)